213 related articles for article (PubMed ID: 35129593)
1. Temporal Correlation Between Kawasaki Disease and Infectious Diseases in South Korea.
Kang JM; Jung J; Kim YE; Huh K; Hong J; Kim DW; Kim MY; Jung SY; Kim JH; Ahn JG
JAMA Netw Open; 2022 Feb; 5(2):e2147363. PubMed ID: 35129593
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Pediatric Admissions for Kawasaki Disease or Infectious Disease During the COVID-19 State of Emergency in Japan.
Hara T; Furuno K; Yamamura K; Kishimoto J; Mizuno Y; Murata K; Onoyama S; Hatae K; Takemoto M; Ishizaki Y; Kanno S; Sato K; Motomura Y; Sakai Y; Ohga S; Yashiro M; Nakamura Y; Hara T
JAMA Netw Open; 2021 Apr; 4(4):e214475. PubMed ID: 33822065
[TBL] [Abstract][Full Text] [Related]
3. Impact of Social Distancing on Kawasaki Disease-associated Hospitalization, South Korea.
Hwangbo J; Lee JS; Choe SA; Choe YJ
Pediatr Infect Dis J; 2021 Oct; 40(10):e383-e384. PubMed ID: 34030170
[TBL] [Abstract][Full Text] [Related]
4. Respiratory pathogen trends in patients with Kawasaki disease during the COVID-19 pandemic and respiratory syncytial virus epidemic in Japan.
Namba T; Higuchi Y; Shimizu J
Pediatr Neonatol; 2023 Sep; 64(5):505-511. PubMed ID: 36878812
[TBL] [Abstract][Full Text] [Related]
5. Delineating phenotypes of Kawasaki disease and SARS-CoV-2-related inflammatory multisystem syndrome: a French study and literature review.
Cherqaoui B; Koné-Paut I; Yager H; Bourgeois FL; Piram M
Rheumatology (Oxford); 2021 Oct; 60(10):4530-4537. PubMed ID: 33493353
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of Kawasaki Disease in South Korea: A Nationwide Survey 2015-2017.
Kim GB; Eun LY; Han JW; Kim SH; Yoon KL; Han MY; Yu JJ; Choi JW; Rhim JW
Pediatr Infect Dis J; 2020 Nov; 39(11):1012-1016. PubMed ID: 33075217
[TBL] [Abstract][Full Text] [Related]
7. Epidemiologic features of Kawasaki disease in South Korea: data from nationwide survey, 2009-2011.
Kim GB; Han JW; Park YW; Song MS; Hong YM; Cha SH; Kim DS; Park S
Pediatr Infect Dis J; 2014 Jan; 33(1):24-7. PubMed ID: 24064559
[TBL] [Abstract][Full Text] [Related]
8. Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Children: One Year after the Onset of the Pandemic in a High-Incidence Area.
Fabi M; Filice E; Biagi C; Andreozzi L; Palleri D; Mattesini BE; Rizzello A; Gabrielli L; Ghizzi C; Di Luca D; Caramelli F; De Fanti A; Lanari M
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696451
[TBL] [Abstract][Full Text] [Related]
9. Epidemiologic Study on Kawasaki Disease in Korea, 2007-2014: Based on Health Insurance Review & Assessment Service Claims.
Ha S; Seo GH; Kim KY; Kim DS
J Korean Med Sci; 2016 Sep; 31(9):1445-9. PubMed ID: 27510389
[TBL] [Abstract][Full Text] [Related]
10. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and Clinical Features of Kawasaki Disease in South Korea, 2012-2014.
Kim GB; Park S; Eun LY; Han JW; Lee SY; Yoon KL; Yu JJ; Choi JW; Lee KY
Pediatr Infect Dis J; 2017 May; 36(5):482-485. PubMed ID: 27997519
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological and Clinical Features of Kawasaki Disease During the COVID-19 Pandemic in the United States.
Burney JA; Roberts SC; DeHaan LL; Shimizu C; Bainto EV; Newburger JW; Dominguez S; Jone PN; Jaggi P; Szmuszkovicz JR; Rowley AH; Samuy N; Scalici P; Tremoulet AH; Cayan DR; Burns JC;
JAMA Netw Open; 2022 Jun; 5(6):e2217436. PubMed ID: 35713905
[TBL] [Abstract][Full Text] [Related]
13. Reduction in Kawasaki Disease After Nonpharmaceutical Interventions in the COVID-19 Era: A Nationwide Observational Study in Korea.
Kang JM; Kim YE; Huh K; Hong J; Kim DW; Kim MY; Jung SY; Kim JH; Jung J; Ahn JG
Circulation; 2021 Jun; 143(25):2508-2510. PubMed ID: 34092115
[No Abstract] [Full Text] [Related]
14. Incidence of Kawasaki disease before and during the COVID-19 pandemic: a retrospective cohort study in Japan.
Iio K; Matsubara K; Miyakoshi C; Ota K; Yamaoka R; Eguchi J; Matsumura O; Okutani T; Ueda I; Nishiyama M
BMJ Paediatr Open; 2021; 5(1):e001034. PubMed ID: 33884312
[TBL] [Abstract][Full Text] [Related]
15. The wide spectrum of Kawasaki-like disease associated with SARS-CoV-2 infection.
Berardicurti O; Conforti A; Ruscitti P; Cipriani P; Giacomelli R
Expert Rev Clin Immunol; 2020 Dec; 16(12):1205-1215. PubMed ID: 33152254
[No Abstract] [Full Text] [Related]
16. Update on SARS-CoV-2 infection in children.
Martins MM; Prata-Barbosa A; da Cunha AJLA
Paediatr Int Child Health; 2021 Feb; 41(1):56-64. PubMed ID: 33616026
[TBL] [Abstract][Full Text] [Related]
17. Pediatric COVID-19 infection in Sulaimaniyah Governorate, Iraq.
Salih AF; Hamasalih K; Rahman HS; Mohammed GA
Am J Otolaryngol; 2022; 43(1):103199. PubMed ID: 34560597
[TBL] [Abstract][Full Text] [Related]
18. Seasonal Trends of Viral Prevalence and Incidence of Kawasaki Disease: A Korea Public Health Data Analysis.
Lim JH; Kim YK; Min SH; Kim SW; Lee YH; Lee JM
J Clin Med; 2021 Jul; 10(15):. PubMed ID: 34362085
[TBL] [Abstract][Full Text] [Related]
19. Kawasaki disease and influenza-new lessons from old associations.
Banday AZ; Arul A; Vignesh P; Singh MP; Goyal K; Singh S
Clin Rheumatol; 2021 Jul; 40(7):2991-2999. PubMed ID: 33387094
[TBL] [Abstract][Full Text] [Related]
20. Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis.
Ouldali N; Pouletty M; Mariani P; Beyler C; Blachier A; Bonacorsi S; Danis K; Chomton M; Maurice L; Le Bourgeois F; Caseris M; Gaschignard J; Poline J; Cohen R; Titomanlio L; Faye A; Melki I; Meinzer U
Lancet Child Adolesc Health; 2020 Sep; 4(9):662-668. PubMed ID: 32622376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
